| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C10orf110 | Enterovirus 71 (GDFS-3 strain of EV 71) | 10^2 TCID50/mL ;
24 hr |
RD Human embryonal rhabdomyosarcoma cells | Microarray | 2.4408426 | Upregulation | p < 0.05 | GeneSpring GX v12.0 software package (Agilent Technologies) | Not provided | 2013 | 23220233 |
| C10orf110 | Enterovirus 71 (GDFS-3 strain of EV 71) | 10^2 TCID50/mL ;
24 hr |
RD Human embryonal rhabdomyosarcoma cells | Microarray | 2.214988 | Upregulation | p < 0.05 | GeneSpring GX v12.0 software package (Agilent Technologies) | Not provided | 2013 | 23220233 |
| IDI2-AS1 | Influenza A virus (A_Puerto Rico_8_34 (H1N1) strain of IAV) | MOI = 2 ;
24 hr |
Primary Human Bronchial epithelial (NHBE) cells | RNA-Seq | 0.487552911 | Downregulation | 1 | student's t test | 2020 | 32416070 | |
| IDI2-AS1 | Middle East Respiratory Syndrome Coronavirus (EMC_2012 strain of (MERS-CoV)) | MOI = 3 ;
24 hr |
MRC-5 Human fetal lung fibroblast cells | RNA-Seq | 4.454458305 | Upregulation | 4.24E-15 | student's t test | 2020 | 32416070 | |
| IDI2-AS1 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI = 2 ;
24 hr |
Calu-3 Human adenocarcinomic lung epithelialcells | RNA-Seq | 2.300743257 | Upregulation | 0.004569987 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose